Ultima Genomics^® and Gene by Gene^® Partner To Expand Sequencing

Ultima Genomics, Inc. and Gene by Gene, announced a partnership to broaden worldwide access to high-quality, cost-effective DNA sequencing.

Through this collaboration, Gene by Gene will join Ultima’s growing network of Certified Service Providers—offering whole genome sequencing and other genomic applications on the UG 100. Leveraging Ultima’s scalable sequencing architecture, Gene by Gene will deliver industry-leading DNA analysis services for clinical, research, direct-to-consumer (DTC), and forensic applications. They will join current Certified Service Provider partners, including Broad Clinical Labs, Inocras, Macrogen, New York Genome Center, Ontario Institute for Cancer Research, Novogene, Psomagen, and the University of Minnesota Genomics Center.

“Ultima Genomics’ unique sequencing platform architecture supports a range of genomics applications by providing cost-effective sequencing at unprecedented scale,” said Jay Therrien, Ph.D., Chief Commercial Officer of Ultima Genomics. “We are excited to partner with Gene by Gene to expand access to the UG 100 for researchers and organizations around the world.”

“Gene by Gene has always been committed to making advanced genetic testing more accessible without compromising quality,” said Josh Wittner, President of Gene by Gene. “Partnering with Ultima allows us to harness the power of the UG 100 to deliver exceptional sequencing output and affordability to our clients globally. It opens new opportunities for discovery, innovation, and impact.”

The collaboration will leverage the UG 100 sequencing platform and UG 100 Solaris^TM, Ultima’s recently launched chemistry, improved software and simplified workflows. Solaris provides more than a 50 percent increase in sequencing output per run over the prior chemistry—up to 10 to 12 billion reads per wafer—while reducing sequencing costs and enabling simplified workflows for customers.